DNA
Ginkgo Bioworks Holdings, Inc.
NYSE · Healthcare · Biotechnology · US
$10.07
−1.95%Oct 13, 2026, 13:00 UTC
Switch Bioworks entered a strategic collaboration with Bayer CropScience AG to combine Switch’s microbial strains with Bayer’s crop hybrids and advance switchable biofertilizer technology.
Oct 9, 2026, 16:26 UTC
Ginkgo Bioworks Holdings, Inc. is providing remote laboratory access through the The National Science Foundation's Ginkgo Bioworks Holdings, Inc. program and integrating high-speed cellular imaging tools into its Boston facility.
Source:Oct 8, 2026, 20:10 UTC
Ginkgo Bioworks Holdings, Inc. announced that it will provide researchers in the The National Science Foundation’s X-Labs program with in-kind access to its autonomous Boston laboratory, including cloud lab time and protein testing services.
Source:Oct 8, 2026, 10:00 UTC
Araceli Biosciences and Ginkgo Bioworks Holdings, Inc. announced the integration of Araceli’s Endeavor high-content imaging instrument into Nebula, Ginkgo’s autonomous laboratory in Boston.
Oct 7, 2026, 23:16 UTC
Ginkgo Bioworks Holdings, Inc. shares closed at $11.47, down 7.57% from the previous trading session.
Source:Oct 6, 2026, 11:30 UTC
Inductive Bio launched Indy, an AI assistant for recurring medicinal chemistry tasks, and Beacon-2, a predictive model for designing compounds with lower estimated human doses.
Source:Oct 1, 2026, 23:15 UTC
Ginkgo Bioworks Holdings, Inc. (DNA) shares fell 2.57% to close at $12.5 on the most recent trading day.
Source:Sep 30, 2026, 20:42 UTC
Standard BioTools entered into a new purchase agreement with Element Biosystems, a subsidiary of GMT Venture, to sell its mass cytometry business after deeming GMT Venture's unsolicited acquisition proposal superior.
Source:Sep 29, 2026, 12:00 UTC
Ginkgo Datapoints and Berlin-based Apheris announced the launch of the Antibody Developability Consortium with founding members to build the field's largest standardised antibody developability dataset.
Source:Sep 23, 2026, 23:15 UTC
Ginkgo Bioworks Holdings, Inc. (DNA) shares closed at $8.58, down 8.43% from the previous trading day.
Source:Sep 18, 2026, 17:35 UTC
Ginkgo Bioworks (DNA) shares surged 11.1% in the prior trading session on higher-than-average trading volume.
Source:Sep 16, 2026, 23:15 UTC
Ginkgo Bioworks Holdings, Inc. (DNA) shares rose 1% to close at $7.06 in the most recent trading session.
Source:Aug 8, 2026, 04:04 UTC
Ginkgo Bioworks reported second-quarter 2026 revenue of $20 million, down 48% from the year-earlier period.
Source: